ArticleNPJ vaccines2024

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

Francisco J Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.